Encomenda rápida

Text Size:AAA

BTLA/CD272  Proteína

All BTLA Reagents

Anfitrião da expressão: Human Cells  
  • Slide 1
11895-H02H-50
11895-H02H-100
50 µg 
100 µg 
Add to Cart
Anfitrião da expressão: Human Cells  
  • Slide 1
51060-M02H-50
51060-M02H-100
50 µg 
100 µg 
Add to Cart
Anfitrião da expressão: Human Cells  
  • Slide 1
81142-R05H-50
81142-R05H-100
50 µg 
100 µg 
Add to Cart
Anfitrião da expressão: Human Cells  
  • Slide 1
90250-C02H-50
90250-C02H-100
50 µg 
100 µg 
Add to Cart

Browse BTLA/CD272 Products by

BTLA/CD272 Caminhos relacionados

BTLA/CD272 Produtos relacionados

BTLA/CD272 Produtos relacionados

Featured Reagent Products

BTLA/CD272 Informações relativas a proteínas e resumo

BTLA/CD272 Fundo

Resumo de gene: BTLA gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in BTLA gene have been associated with an increased risk of rheumatoid arthritis. [provided by RefSeq, Aug 2011]
General information above from NCBI
Estrutura da subunidade: Interacts with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2. Interacts with TNFRSF14/HVEM.
Localização subcelular: Membrane; Single-pass type I membrane protein (Potential).
Pós-translacional: Phosphorylated on Tyr residues by TNFRSF14 and by antigen receptors cross-linking, both inducing association with PTPN6 and PTPN11.
N-glycosylated.
Semelhança da sequência: Contains 1 Ig-like V-type (immunoglobulin-like) domain.
General information above from UniProt

BTLA is a inhibitory molecule which belongs to the Ig superfamily. It down-modulates immune responses. As such, reagents that regulate the binding of BTLA to its ligand or alter BTLA signaling have significant therapeutic promise. BTLA is crucial to understand the mechanism(s) of action of these antibodies before attempting clinical applications. BTLA is not expressed by naive T cells, but it is induced during activation and remains expressed on T helper type 1 (T(H)1) but not T(H)2 cells. BTLA is a third inhibitory receptor on T lymphocytes with similarities to cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed death 1 (PD-1).

BTLA/CD272 Nome alternativo

BTLA1,CD272, [homo-sapiens]
B and T lymphocyte attenuator,B- and T-lymphocyte attenuator,B- and T-lymphocyte-associated protein,BTLA1,CD272, [human]
A630002H24,B and T lymphocyte attenuator,B- and T-lymphocyte attenuator,B- and T-lymphocyte-associated protein, [mouse]
A630002H24, [mus-musculus]

BTLA/CD272 Estudos relacionados

  • Fourcade J, et al. (2012) CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1. Cancer Res. 72(4):887-96.
  • Kojima R, et al. (2011) Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT. J Mol Biol. 413(4):762-72.
  • Oki M, et al. (2011) A functional polymorphism in B and T lymphocyte attenuator is associated with susceptibility to rheumatoid arthritis. Clin Dev Immunol. 305656.
  • Tenha em atenção o seguinte: Todos os produtos destinam-se "A FINS EXCLUSIVOS DE INVESTIGAÇÃO E NÃO DEVEM SER UTILIZADOS PARA EFEITOS DE DIAGNÓSTICO OU TERAPÊUTICOS"